Page 50 - Mobile Android News Today

BioXcel Therapeutics has announced the FDA approval of Igalmi, a sublingual film for acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

The foods we eat can affect our risk for developing certain types of cancer. Obesity can increase the risk for some cancers, meaning that a varied diet of nutritious foods may help prevent cancer. It is estimated that about 30% of the risk for cancer can be attributed to diet, which is just below tobacco smoke and far, far above any other known risk factor.

CHICAGO — Based on results of a recent survey of senior residents, a presenter said cementing femoral stems during total hip arthroplasty is an area of orthopedic training and skill that likely can be improved.During a Hip Society session held on specialty day at the American Academy of Orthopaedic Surgeons Annual Meeting, James A. Browne, MD, FAAOS, discussed results of 152 surveys that

Patients with rheumatic and musculoskeletal diseases should engage in both aerobic and strengthening exercises, aiming for at least moderate intensity, according to new EULAR recommendations.The recommendations, which cover lifestyle behaviors and work participation to prevent rheumatic and musculoskeletal disease progression, also state that patients should be counseled that “it is never

Cancer centers, advocacy groups and other organizations have ramped up efforts to reduce disparities across the cancer care continuum, according to presenters at the virtual National Comprehensive Cancer Network 2022 Annual Conference.“Despite Black individuals having higher incidence and/or mortality compared with white individuals in the U.S. for the most common cancer types — and

Twice-daily Vuity for presbyopia met its primary efficacy endpoint in the phase 3 VIRGO trial, according to a press release from Allergan/AbbVie.Vuity (pilocarpine HCl ophthalmic solution 1.25%) improved near vision without compromising distance vision at hour 9, 3 hours after the second drop, on day 14 of the study, the release said.

WASHINGTON — Treatment with vupanorsen, a novel antisense oligonucleotide targeting hepatic ANGPTL3, achieved modest reductions in non-HDL at 24 weeks at all doses studied, according to results of the TRANSLATE-TIMI 70 trial.Patients assigned vupanorsen at higher doses had increased rates of injection-site reactions, elevations in liver enzymes and dose-related increases in hepatic fat

WASHINGTON — Contrary to guideline recommendations, most patients with infections related to implantable cardiac devices do not get their devices explanted, despite extraction leading to better outcomes, researchers reported. Sean D. Pokorney, MD, MBA, assistant professor of medicine at Duke University School of Medicine and member in the Duke Clinical Research Institute, presented

Simulations revealed that using deceased donor kidneys in transplant chains could increase the number of transplants by 290 a year, according to data published in the Kidney International Reports.Further, investigators noted that using deceased donors (DD) can increase transplantations for blood type O kidney-paired donation (KPD) candidates.

Indiana University Melvin and Bren Simon Comprehensive Cancer network has become the newest National Comprehensive Cancer Network member institution.NCCN is a not-for-profit alliance of 32 leading academic cancer centers devoted to patient care, research and education.